Integrative Pancreatic Intervention Therapy. A Holistic Approach

Table of Contents

Part One Basics and transformation research of pancreatic diseases 1. Anatomy and physiology of pancreas 2. Epidemiology, pathological anatomy and pathophysiology of pancreatic diseases 3. Clinical laboratory and imaging diagnosis of pancreatic diseases 4. Medical therapy of pancreatic diseases 5. Surgical treatment of pancreatic diseases 6. Emergency and critical care medicine of pancreatic diseases 7. Transformation and application advances of pancreatic diseases

Part Two Interventional therapy for benign pancreatic disease 8. Clinical interventional therapy for pancreatitis 9. Clinical interventional therapy for pancreatic cyst 10. Clinical interventional therapy for pancreatic paracrisis

Part Three Interventional therapy for malignant pancreatic diseases 11. Arterial infusion and arterial chemoembolization therapy for pancreatic cancer 12. Radioactive particles implantation for pancreatic cancer 13. Radiofrequency and microwave ablation for pancreatic cancer 14. Nano-knife for pancreatic cancer 15. HIFU for pancreatic cancer

Part Four Interventional Therapy for pancreatic cancer-related lesions 16. Minimally Invasive Interventional treatment for Pancreatic carcinoma induced obstructive jaundice 17. Minimally Invasive Interventional treatment for Pancreatic carcinoma induced Intestinal Obstruction 18. Minimally Invasive Interventional treatment for Pancreatic carcinoma induced intractable pain

Part Five Stem cell and targeted molecular therapy for pancreatic carcinoma 19. Recent progresses in Stem cell therapy for pancreatic carcinoma 20. Recent progresses in Targeted molecular therapy for pancreatic carcinoma 21. Recent progresses in Immunotherapy for pancreatic carcinoma

Part Six Combined Interventional Therapy for pancreatic carcinoma 22. Interventional Therapy combined with intravenous chemotherapy pancreatic carcinoma 23. Interventional Therapy Combined with Radiotherapy for pancreatic carcinoma 24. Combined Interventional and Targeted Molecular Therapy for Pancreatic Carcinoma 25. Strategies and Methods for Selecting suitable combined Interventional Therapy for Pancreatic Carcinoma 26. Recent development and future prospects of Interventional Therapy for Pancreatic Carcinoma

Authors

Ligong Lu Chief Physician, doctoral tutor, and Dean of Zhuhai Hospital, affiliated with Tongji University. Shanghai, China. Ligong Lu is Chief Physician, doctoral tutor, and Dean of Zhuhai Hospital, affiliated with Tongji University. He is deputy director of the Institute of Interventional Vascular Research, and Director of the Zhuhai Intervention Centre, and the Zhuhai Precision Medical Treatment Centre. He is a doctoral tutor at Jinan University, Southern Medical University, and Guangdong Provincial Institute of Cardiovascular Disease, as well as a Professor at Macao University. He has been a senior visiting scholar at the Wayne State University Detroit Medical Center. His research focuses on basic and clinical interventional radiology, liver cancer, and malignancies. Yueyong Xiao Deputy Director of Radiology, Shanghai Military Hospital, Shanghai, China. Yueyong Xiao is Deputy Director of Radiology at Shanghai Military Hospital. He is Chief Physician, and a doctoral tutor, as well as an executive member of the International Refrigeration Association, and President of the Asian Frozen Society. His work in imaging diagnosis and interventional therapy spans 30 years. He carries out CT and MRI guided minimal invasive surgery. He has been a senior visiting scholar at Harvard Medical College, specializing in CT, and MRI-guided interventional therapy. Deliang Fu Director of Pancreatic Surgery at Huashan hospital, affiliated with Fudan University, Fudan, China. Deliang Fu is the Director of Pancreatic Surgery at Huashan hospital, affiliated with Fudan University in China, and the Director of the Pancreatic Cancer Treatment Center at Fudan University. He is also deputy director of the Institute of Pancreatic Diseases, also at Fudan University, and vice-chairman of the Pancreas Division of the Shanghai Medical Association, as well as a doctoral tutor. He has published widely in the field, both research papers and book chapters, and has led a number of National Natural Science Foundation and Ministry of Health research projects. Haijun Zhang Director of the National Engineering Laboratory of Biomedical Material Modification Technology, and deputy director of the Institute of Interventional Vascular Research, Tongji University, Shanghai, China. Haijun Zhang is Director of the National Engineering Laboratory of Biomedical Material Modification Technology, and deputy director of the Institute of Interventional Vascular Research, at Tongji University in China. He is also Director of the strategic alliance for the medical material modification industry. He focuses on biomedical material modification, including in medical material engineering, medical engineering, and transformational medicine.